Manulife (Manufacturers Life Insurance)
LRMR icon

Manulife (Manufacturers Life Insurance)’s Larimar Therapeutics LRMR Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60.5K Sell
13,445
-2,507
-16% -$10K ﹤0.01% 2716
2025
Q4 		$60.8K Buy
15,952
+402
+3% +$1.56K ﹤0.01% 2787
2025
Q3 		$50.2K Sell
15,550
-615
-4% -$2.31K ﹤0.01% 2881
2025
Q2 		$46.7K Sell
16,165
-51
-0.3% -$118 ﹤0.01% 2895
2025
Q1 		$34.9K Buy
16,216
+513
+3% +$1.62K ﹤0.01% 2860
2024
Q4 		$60.8K Sell
15,703
-458
-3% -$3.02K ﹤0.01% 2915
2024
Q3 		$106K Sell
16,161
-454
-3% -$3.65K ﹤0.01% 2855
2024
Q2 		$120K Buy
+16,615
New +$127K ﹤0.01% 2780
2019
Q1 		– Sell
-874
Closed -$52K – 2636
2018
Q4 		$52K Sell
874
-122
-12% -$12K ﹤0.01% 2482
2018
Q3 		$140K Buy
996
+904
+983% +$110K ﹤0.01% 2849
2018
Q2 		$11K Hold
92
– – ﹤0.01% 3869
2018
Q1 		$8K Buy
92
+67
+268% +$5.68K ﹤0.01% 3986
2017
Q4 		$1K Hold
25
– – ﹤0.01% 4271
2017
Q3 		$1K Sell
25
-51
-67% -$2.12K ﹤0.01% 4170
2017
Q2 		$3K Sell
76
-376
-83% -$19.2K ﹤0.01% 4049
2017
Q1 		$26K Buy
452
+388
+606% +$19.3K ﹤0.01% 3485
2016
Q4 		$2K Hold
64
– – ﹤0.01% 4113
2016
Q3 		$3K Hold
64
– – ﹤0.01% 3999
2016
Q2 		$5K Sell
64
-910
-93% -$71.9K ﹤0.01% 3800
2016
Q1 		$74K Buy
974
+47
+5% +$3.71K ﹤0.01% 3176
2015
Q4 		$70 Hold
927
– – ﹤0.01% 3203
2015
Q3 		$355 Buy
927
+19
+2% +$8.57K ﹤0.01% 2223
2015
Q2 		$377 Buy
908
+429
+90% +$179K ﹤0.01% 2323
2015
Q1 		$228 Buy
479
+202
+73% +$95.9K ﹤0.01% 2636
2014
Q4 		$103 Buy
+277
New +$71.4K ﹤0.01% 3059

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s LRMR Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Larimar Therapeutics (LRMR) stake by 16% in Q1 2026, selling an estimated $10K and leaving 13,445 shares worth $60.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2716.

Manulife (Manufacturers Life Insurance) first reported a position in LRMR in Q4 2014 and has held it in 25 quarters since. The position peaked at $140K in Q3 2018. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 13,445 shares of Larimar Therapeutics worth $60.5K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 2,507 Larimar Therapeutics shares in Q1 2026, an estimated $10K.
  • Larimar Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2716 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Larimar Therapeutics in Q4 2014 and has held it in 25 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Larimar Therapeutics position peaked at $140K in Q3 2018.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.